XML 67 R27.htm IDEA: XBRL DOCUMENT v3.19.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 27, 2019
Share-based Payment Arrangement [Abstract]  
Allocated Employee Stock-Based Compensation Expense
We allocated the stock-based compensation expense for our equity incentive plans and our 2000 Employee Stock Purchase Plan (ESPP) as follows (in thousands):
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2019
 
2018
 
2019
 
2018
Research and development
$
4,301

 
$
3,169

 
$
13,745

 
$
9,102

Selling, general and administrative
8,838

 
6,573

 
27,002

 
19,228

Total stock-based compensation
$
13,139

 
$
9,742

 
$
40,747

 
$
28,330


Weighted Average Grant-Date Fair Value of Stock Options and ESPP Purchases The weighted average grant-date fair value per share of stock options and ESPP purchases were as follows:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2019
 
2018
 
2019
 
2018
Stock options
$
7.71

 
$
8.67

 
$
8.57

 
$
9.13

ESPP
$
5.39

 
$
6.19

 
$
4.93

 
$
6.96


Valuation Assumptions Used to Estimate Grant-Date Fair Value
The grant-date fair value of stock option grants and ESPP purchases was estimated using the following assumptions:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2019
 
2018
 
2019
 
2018
Stock options:
 
 
 
 
 
 
 
Risk-free interest rate
1.57
%
 
2.91
%
 
1.82
%
 
2.83
%
Dividend yield
%
 
%
 
%
 
%
Volatility
48
%
 
55
%
 
48
%
 
55
%
Expected life
4.0 years

 
4.4 years

 
4.4 years

 
4.4 years

ESPP:
 
 
 
 
 
 
 
Risk-free interest rate
2.09
%
 
2.11
%
 
2.34
%
 
1.74
%
Dividend yield
%
 
%
 
%
 
%
Volatility
43
%
 
51
%
 
52
%
 
52
%
Expected life
6 months

 
6 months

 
6 months

 
6 months


Stock Option Activity
Activity for stock options during the nine months ended September 30, 2019 was as follows (dollars in thousands, except per share amounts):
 
Shares
 
Weighted
Average
Exercise Price Per Share
 
Weighted
Average
Remaining Contractual
Term
 
Aggregate
Intrinsic
Value
Options outstanding at December 31, 2018
22,674,062

 
$
8.71

 
 
 
 
Granted
1,042,286

 
$
20.81

 
 
 
 
Exercised
(3,042,201
)
 
$
4.94

 
 
 
 
Forfeited
(160,241
)
 
$
16.76

 
 
 
 
Expired
(35,045
)
 
$
23.41

 
 
 
 
Options outstanding at September 30, 2019
20,478,861

 
$
9.80

 
3.4 years
 
$
186,407

Exercisable at September 30, 2019
15,860,131

 
$
7.02

 
2.8 years
 
$
181,542


RSU Activity
Activity for RSUs during the nine months ended September 30, 2019 was as follows (dollars in thousands, except per share amounts):
 
Shares
 
Weighted
Average
Grant Date
Fair Value Per Share
 
Weighted
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value
RSUs outstanding at December 31, 2018
4,857,334

 
$
18.42

 
 
 
 
Awarded
5,635,362

 
$
19.54

 
 
 
 
Vested and released
(484,731
)
 
$
12.33

 
 
 
 
Forfeited
(258,142
)
 
$
18.47

 
 
 
 
RSUs outstanding at September 30, 2019
9,749,823

 
$
19.37

 
2.2 years
 
$
175,448